Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Captions (Tables)

v3.20.1
Composition of Certain Financial Statement Captions (Tables)
3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Composition of Certain Financial Statement Captions
(In thousands)
March 31,
2020
 
December 31,
2019
Accounts receivable, net:
 
 
 
Accounts receivable
$
134,223

 
$
136,551

Less: allowance for credit losses
(1,747
)
 
(1,934
)
 
$
132,476

 
$
134,617

Inventories, net:
 
 
 
Consumable supplies
$
28,010

 
$
23,005

Finished products
23,729

 
25,142

Work in-process
4,260

 
3,238

Raw materials
4,591

 
4,586

Less: inventory reserve
(1,893
)
 
(2,537
)
 
$
58,697

 
$
53,434

Other current assets and prepaid expenses:
 
 
 
Taxes recoverable
$
13,577

 
$
19,808

Prepaid expenses
12,602

 
8,147

Prepaid insurance
6,143

 
3,486

Other receivables
646

 
3,262

Other
15,786

 
15,839

 
$
48,754

 
$
50,542

Intangible assets, net:
 
 
 
Customer relationships
$
444,328

 
$
445,408

Technologies
296,169

 
296,246

Trade names
49,760

 
49,786

Covenants not to compete
16,315

 
16,318

Licenses
5,766

 
5,766

Product registrations
6,876

 
7,578

Other
6,007

 
6,094

Less: accumulated amortization
(311,710
)
 
(298,234
)
 
$
513,511

 
$
528,962

Accrued expenses:
 
 
 
Contract liabilities
$
10,455

 
$
19,196

Employee benefits
35,325

 
33,671

Commitments and Contingencies
37,647

 
38,635

Clinical trials
7,540

 
8,122

Contingent consideration
2,375

 
2,375

Finance leases short-term
2,598

 
2,743

Professional fees
903

 
1,333

Other
68,096

 
58,850

 
$
164,939

 
$
164,925

 
 
 
 

(In thousands)
March 31,
2020
 
December 31,
2019
Other long-term liabilities:
 
 
 
Line of credit
$
39,311

 
$
44,749

Contingent consideration
6,448

 
7,308

Mortgages and other debts payable
3,538

 
3,906

Finance leases long-term
3,489

 
4,046

Contract liabilities
1,861

 
2,571

Other
23,115

 
25,224

 
$
77,762

 
$
87,804


Changes in Goodwill
The following table summarizes the changes in Goodwill by reporting unit during the three months ended March 31, 2020.
 
2020
(In thousands)
Balance at January 1
 
Foreign exchange and other
 
Balance at March 31st
Pharmaceuticals
 
 
 
 
 
Rayaldee
$
85,605

 
$
(1,602
)
 
$
84,003

OPKO Chile
4,348

 
(614
)
 
3,734

OPKO Biologics
139,784

 

 
139,784

OPKO Health Europe
7,394

 
(142
)
 
7,252

 
 
 
 
 
 
Diagnostics
 
 
 
 
 
BioReference
434,809

 

 
434,809

 
$
671,940

 
$
(2,358
)
 
$
669,582